Showing 2541-2550 of 2972 results for "".
- BTL Cracks Down on Counterfeit Devices in the U.S.https://modernaesthetics.com/news/btl-cracks-down-on-counterfeit-devices-in-the-us/2473373/BTL is making inroads in its efforts to safeguard medical providers and consumers from counterfeit devices in the United States through legal action and the seizure of illegally imported devices at the border. BTL has filed court documents stating that defendants use and sell knock
- U.S. FDA Clears Renuvion to Coagulate and Contract Soft Tissues, Including Subcutaneous Tissuehttps://modernaesthetics.com/news/fda-clears-of-renuvion-to-coagulate-and-contract-soft-tissues-including-subcutaneous-tissue/2473371/The U.S. Food and Drug Administration (FDA) has cleared the use of the Renuvion APR Handpiece for the delivery of radiofrequency energy and/or helium plasma where coagulation/contraction of soft tissue is needed. (Soft tissue includes subcutaneous tissue.) “We are pleas
- Vaginal Laser Treatment Shows Promise in Treating OABhttps://modernaesthetics.com/news/vaginal-laser-treatment-shows-promise-in-treating-oab/2473368/Vaginal laser surgery may be effective in treating overactive bladder syndrome (OAB), according to a study in Menopause. Erbium: Yttrium-Aluminum-Garnet (Erbium YAG) vaginal laser treatment is already used to treat various symptoms of the genitourinary syndrome of menopause, vagina
- Business News: BeautyHealth Buys SkinStylushttps://modernaesthetics.com/news/business-news-beautyhealth-buys-skinstylus/2473366/The Beauty Health Company is set to acquire SkinStylus, a US Food and Drug Adminstrayion -cleared microneedling device. The agreement represents a key step forward in BeautyHealth’s portfolio build-up strategy. Upon successful integration of SkinStylus into the BeautyHealth
- Neauvia Granted CE Marking Under the E.U.’s New MDR for Facial Dermal Filler Linehttps://modernaesthetics.com/news/neauvia-granted-ce-marking-under-the-eus-new-mdr-for-facial-dermal-filler-line/2473362/Neauvia scored CE marking under the European Union’s new MDR (Medical Device Regulation) for its range of facial dermal fillers products, making it the first medical aesthetics business to receive such certification in Europe. The new regulation aims to create ‘a robus
- CoolHealth Rolls Out TargetCool for Post-Procedure Pain Controlhttps://modernaesthetics.com/news/coolhealth-rolls-out-targetcool-for-post-procedure-pain-controlmo/2473359/CoolHealth is entering the U.S. market with TargetCool. Leveraging tuneable cooling technology, TargetCool rapidly cools the skin, allowing providers to specifically set a “target” skin temperature down to the exact degree and secon
- Industry Vet Crystal Muilenburg Joins Elevai’s Board of Directorshttps://modernaesthetics.com/news/industry-vet-crystal-muilenburg-joins-elevais-board-of-directors/2473357/Crystal Muilenburg is the newest member of Elevai’s Board of Directors. A former Evolus and Allergan executive, Muilenburg will play a key role in supporting the Elevai management team as it commercializes Elevai’s flagship exosome product line while driving t
- iCRYO to Bring BTL Devices to Franchiseshttps://modernaesthetics.com/news/icryo-to-bring-btl-devices-to-franchises/2473353/iCRYO is partnering with BTL Industries to bring BTL’s suite of devices to their franchises. “We are going into a multi-year purchasing agreement to onboard several hundred devices over that time period. We are working on launching our "EMsuite" within the iC
- Dermalogica Releases Course on Treating Melanin-Rich Skinhttps://modernaesthetics.com/news/dermalogica-releases-course-on-treating-melanin-rich-skin-1/2473350/In a move to address under-representation in the professional skin care industry’s training curricula regarding melanin-rich skin tones (specifically those categorized as Fitzpatrick levels IV-VI), Dermalogica announced it is launching “Treating Melanin-Rich Skin.” <
- Game Change: Galderma Launches FACE by Galdermahttps://modernaesthetics.com/news/galderma-launches-face-by-galderma/2473349/Galderma is launching FACE by Galderma, an app that simulates the results of injectable treatments in real time using digital facial assessment. The technology was unveiled at the International Master Course on Aging Science (IMCAS) World Congress 2023 in Paris. FACE by Galder